Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01477697 · ClinicalTrials.gov registry record · Phase 1
Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients
A Phase 1 study, sponsored by University of Cincinnati.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01477697 is a Phase 1 study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 12 participants.
The verdict
NCT01477697, a Phase 1 study, was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study will evaluate the effects of omega-3 fatty acid supplementation on inflammation in trauma patients. The main hypothesis is that such supplementation will reduce the presence of biomarkers of systemic inflammation, as compared to placebo
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Omega-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01477697
The ClinicalTrials.gov registry entry for NCT01477697 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01477697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01477697 about?
NCT01477697 is a clinical study titled "Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients". This study will evaluate the effects of omega-3 fatty acid supplementation on inflammation in trauma patients. The main hypothesis is that such supplementation will reduce the presence of biomarkers of systemic inflammation, as compared to placebo
What is the current status of trial NCT01477697?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2011-06. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01477697?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Omega-3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01477697?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.